Patents by Inventor Rahimdzhan Roziev

Rahimdzhan Roziev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agent for the prophylaxis and/or treatment of neoplastic diseases
    Patent number: 9949961
    Abstract: The invention relates to a novel agent in the form of rhodanine derivatives, which has prophylactic, antiproliferative and antimetastatic activity. Said agent can find use in medicine and pharmacology for the prophylaxis and/or treatment of neoplastic diseases of variable localization.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: April 24, 2018
    Inventors: Rahimdzhan Roziev, Anna Ya. Goncharova, Kenes T. Erimbetov, Vladimir Podgorodnichenko, Victor Khomichenok, Natal'ja Novozhilova
  • AGENT FOR THE PROPHYLAXIS AND/OR TREATMENT OF NEOPLASTIC DISEASES
    Publication number: 20160038472
    Abstract: The invention relates to a novel agent in the form of rhodanine derivatives, which has prophylactic, antiproliferative and antimetastatic activity. Said agent can find use in medicine and pharmacology for the prophylaxis and/or treatment of neoplastic diseases of variable localisation.
    Type: Application
    Filed: March 12, 2014
    Publication date: February 11, 2016
    Inventors: Rahimdzhan Roziev, Anna Ya. Goncharova, Kenes T. Erimbetov, Vladimir Podgorodnichenko, Victor Khomichenok, Natal'ja Novozhilova
  • CLATHRATE COMPLEX OF CYCLODEXTRIN OR ARABINOGALACTAN WITH 9-PHENYL-SYM-OCTA-HYDROSELENOXANTENE
    Publication number: 20140023713
    Abstract: The invention relates to novel clathrate complexes of cyclodextrin or arabinogalactan with 9-phenyl-sym-octahydroselenoxanthene, possibly in ?-crystalline form, The clathrate complex may be in crystalline form, possibly in the form of nano-particles. In the clathrate complex, cyclodextrin is selected from ?-, ?-, ?- or hydroxypropyl-?-cyclodextrin, primarily ?-cyclodextrin. The proposed clathrate complexes make it possible to increase the water-solubility of the active compound, to improve the bioavailability, to reduce the dosage of the drug and, consequently, to reduce the toxic effect of 9-phenyl-sym-octahydroselenoxanthene. The complexes exhibit cytoradioprotective activity. The invention also relates to a liquid-phase and solid-phase methods for producing clathrate complexes, as well as to pharmaceutical compositions and drugs thereof.
    Type: Application
    Filed: February 20, 2012
    Publication date: January 23, 2014
    Inventors: Anatoliy Fedorovich Tsyb, Anna Yakovlevna Goncharova, Rahimdzhan Roziev, Ilya Vorobyev, Vladimir Podgorodnichenko, Kenes Erimbetov